Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | ALDH3A1 | P30838 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CCR6 | P51684 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL216889 | 0.79 | ALDH1A1 (0.56) | KMT2AMEN1POLBHTTMAPT | |
| SCHEMBL27870034 | 0.78 | KDM4E (0.43) | KMT2AMEN1POLBHTTL3MBTL1 | |
| SCHEMBL29101321 | 0.77 | KDM4E (0.57) | KMT2AMEN1POLBHTTL3MBTL1 | |
| SCHEMBL30614582 | 0.77 | HTT (0.43) | KMT2APOLBHTTMAPTALDH1A1 | |
| SCHEMBL3245827 | 0.74 | POLB (0.42) | KMT2AMEN1POLBHTTL3MBTL1 | |
| SCHEMBL20945468 | 0.74 | F2 (0.51) | KMT2AMEN1HSD11B1POLBHTT | |
| SCHEMBL31301530 | 0.73 | LMNA (0.47) | KMT2AMEN1POLBHTTRAB9A | |
| SCHEMBL28743018 | 0.71 | POLB (0.37) | POLBHTTMAPTALDH1A1LMNA | |
| SCHEMBL18976160 | 0.71 | KMT2A (0.48) | KMT2AMEN1HSD11B1HSP90AA1CXCR5 | |
| SCHEMBL16429191 | 0.70 | GAA (0.50) | KMT2AHSD11B1ALDH3A1POLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110845135-B | Method for manufacturing optical fiber | 株式会社藤仓 | 2022-07-22 | — | — | CN | claimed |
| EP-1712601-B1 | Phase change inks | XEROX CORP (US) | 2010-07-28 | — | — | EP | claimed |
| WO-2025091044-A1 | COMPUTER-IMPLEMENTED METHODS FOR QUANTUM MECHANICAL BINDING AFFINITY SCORING | RUTGERS, THE STATES UNIVERSITY OF NEW JERSEY (US) | 2025-05-01 | — | — | WO | disclosed |
| US-12247214-B2 | Vaccinia viral vectors encoding chimeric virus like particles | GEOVAX, INC. (US) | 2025-03-11 | — | — | US | disclosed |
| WO-2024206243-A1 | PAN-BETACORONAVIRUS VACCINES AND USES THEREOF | GEOVAX. INC. (US) | 2024-10-03 | — | — | WO | disclosed |
| CN-116656786-B | CRISPR-lateral flow nucleic acid detection test paper based on chain hybridization and detection probe thereof | 广州医科大学附属第一医院（广州呼吸中心） | 2024-07-02 | — | — | CN | disclosed |
| WO-2024092629-A1 | USE OF NICOTINAMIDE MONONUCLEOTIDE IN ENHANCING LIFETIME OF CAR-T CELL | 卡瑞济(北京)生命科技有限公司 | 2024-05-10 | — | — | WO | disclosed |
| EP-4306125-A1 | IMMUNOGENIC PERSONALISED CANCER VACCINES | Universität Zürich (CH) | 2024-01-17 | — | — | EP | disclosed |
| US-11807002-B2 | Liquid ejecting apparatus and method of controlling liquid ejecting apparatus | SEIKO EPSON CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| WO-2023183217-A2 | METHODS AND MATERIALS FOR TREATING DYSKERATOSIS CONGENITA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-09-28 | — | — | WO | disclosed |
| CN-116656786-A | CRISPR-lateral flow nucleic acid detection test paper based on chain hybridization and detection probe thereof | 广州医科大学附属第一医院（广州呼吸中心） | 2023-08-29 | — | — | CN | disclosed |
| US-6414051-B1 | MELTING THE INK; EJECTION USING ACOUSTIC BEAMS IN IMAGEWISE PATTERN ONTO RECORDING SHEET | XEROX CORPORATION | 2002-07-02 | — | — | US | disclosed |
| US-6336963-B1 | INK COMPOSITION COMPRISING INK VEHICLE COMPRISING FIRST NITRILE COMPOUND HAVING FIRST VISCOSITY AT MELT TEMPERATURE, VISCOSITY MODIFIER COMPRISING SECOND NITRILE COMPOUND HAVING LOWER VISCOSITY AT MELT TEMPERATURE, COLORANT | XEROX CORPORATION | 2002-01-08 | — | — | US | disclosed |
| EP-0739898-B1 | Phosphonomonoester nucleic acids, methods for their preparation and their use | AVENTIS PHARMA GMBH (DE) | 2001-09-26 | — | — | EP | disclosed |
| CN-1060781-C | Phosphonootropic monoester nucleic acids, process for their preparation and their use | HOECHST AG (DE) | 2001-01-17 | — | — | CN | disclosed |
| US-6127346-A | FOR THE TREATMENT OF VIRUSES | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-10-03 | — | — | US | disclosed |
| US-5874553-A | ANTIBODIES; INHIBITOR OF GENE EXPRESSION | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-02-23 | — | — | US | disclosed |
| CN-1138588-A | Phosphonootropic monoester nucleic acids, process for their preparation and their use | HOECHST AG (DE) | 1996-12-25 | — | — | CN | disclosed |
| EP-0739898-A2 | Phosphonomonoester nucleic acids, methods for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-10-30 | — | — | EP | disclosed |
| US-4719179-A | GENETIC ENGINEERING | PHARMACIA P-L BIOCHEMICALS, INC. (US) | 1988-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12247214-B2 | Vaccinia viral vectors encoding chimeric virus like particles | HAVCR2, VAC14, TTPA | KMT2A 4704/4885MEN1 2711/4885HSD11B1 3808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.